Galindo RK, Rodríguez VJ, González RE, García FL, Hormigó PI

Language: Spanish
References: 14
Page: 113-121
PDF size: 240.10 Kb.

ABSTRACT

Circumscribed choroidal hemangioma is a benign hamartomatous vascular tumor of low incidence. This case is presented for its slow natural history and the poor response to treatment with photodynamic therapy. The 49-year-old male patient with right-eye visual reduction of eight month of evolution and without any other associated symptomatology. Complementary explorations carried out (retinography, OCT, sonogram, fluorescein angiography) evinces a juxtapapillary nasal tumor diagnosed as circumscribed choroidal hemangioma. The decision is to treat it with photodynamic therapy. In this case, despite the fact the visual gain outcome is not the desired, the complementary tests performed revealed a fair improvement. According to the authors, the slow evolution of this patient is due to several factors such as age, visual decay at the time of the diagnosis, the TFD number of applications, the tumor´s time of evolution and the lesion seize.

REFERENCES

1. Madreperla SA. Choroidal hemangioma treated with photodynamic therapy using verteporfin. Arch Ophthalmol. 2001;119:1606-10.

2. Smoker WR, Gentry LR. Vascular lesions of the Orbit: More tan Meets the Eye. Radio Graphics. 2008 Jan;28:185-204.

3. Kanski JJ. Tumores Intraoculares. 5ta ed. Oftalmología Clínica. 2004;11:324-55.

4. García-Arumí J. Hemangioma coroideo: uso de terapia fotodinámica [Internet]. Barcelona: Universidad Autónoma; 2013 [citado 9 Feb 2013]. Disponible en: http://www.imo.es/index.php/es/3/la-terapia-fotodin-mica-demuestra-su-eficaciacontra- un-tumor-ocular

5. Augsburger JJ, Shields JA, Moffat KP. Circumscribed choroidal hemangiomas: long-term visual prognosis. Retina 1981;1:56-61.

6. Andonegui J, Pérez de Arcelus M, Jiménez-Lasanta L. Tratamiento mediante terapia fotodinámica del hemangioma coroideo circunscrito. Arch Soc Esp Oftalmol. 2010;85(10):337-40.

7. Shields CL, Honavar SG, Shields JA. Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology. 2001;108:2237-48.

8. Hoffman DJ. Circumscribed choroidal hemangiomas: A case report and review of the literature. Optometry. 2006;77(8):384-91.

9. Shields JA, Shields CL, Materin NA. Changing concepts in management of circumscribed choroidal hemangioma: The 2003 J Howard Stokes Lecture, Part 1. Ophthalmic Surg Lasers Imaging. 2004;35:383-94.

10. Doran M. Circumscribed Choroidal Hemangioma: PDT Improves Prognosis. Eye Net Magazine [Internet]. American Academy of Ophthalmology; 2007. [citado 9 Dic 2015]. Disponible en: http://www.aao.org/eyenet/article/circumscribed-choroidalhemangiomas- pdt-improves-p

11. Evidence Based Guideline. Photodynamic Therapy Ocular. Blue Cross Blue Shield of North Carolina; 2009.

12. Chiang Rodríguez C, Toledo González Y, Rúa Martínez R, Pérez Pérez M. Modalidades de tratamiento para el hemangioma coroideo circunscrito. Rev Cubana Oftalmol. 2010 [citado 18 Ene 2016];23(Suppl 1):590-607. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 21762010000300014&lng=es&nrm=iso

13. Shields JA, Shields CL, Materian MA, Marr BP, Dermici H, Mashayekhi A. Changing concepts in management of circumscribed choroidal hemangioma: the 2003 J. Howard Stokes Lecture, Part 1. Ophthalmic Surg Lasers Imaging. 2004;35:383-94.

14. Vicuna-Kojchen J, Banin E, Averbukh E, Barzel I, Shulman M, Hemo I, et al. Application of the standard photodynamic treatment protocol for symptomatic circumscribed choroidal hemangioma. Ophthalmologica. 2006;220:351-5.